Augmenting Antidepressants: Exploring Lumateperone and Other Strategies

This chapter reviews a recent clinical trial on lumateperone's effectiveness in augmenting treatment for major depression in unresponsive patients. It compares lumateperone's performance with other FDA-approved options, highlighting aripiprazole as the leading choice based on its effect size and extensive research support.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.